Lal, Jessica C.
Fang, Michelle Z.
Hussain, Muzna
Abraham, Abel
Tonegawa-Kuji, Reina
Hou, Yuan
Chung, Mina K.
Collier, Patrick
Cheng, Feixiong
Article History
Received: 23 July 2024
Accepted: 23 January 2025
First Online: 13 February 2025
Declarations
:
: Patients with a history of cancer and exposure to cytotoxic chemotherapy and who had a clinically necessary echocardiogram assessment were enrolled to approved IRBs #11–194 and #19–1122 as described previously[, ]. Verbal and written informed consent were obtained.
: The authors declare no competing interests.